| |
Re-operation/Cohort members
|
Risk (%)
|
Crude RR (95%CI)
|
Adjusted RR* (95%CI)
|
|---|
|
SSRI Prescription
| | | | |
|
Never
|
338/12872
|
2.6
|
1.0
|
1.0
|
|
Ever
|
51/1592
|
3.2
|
1.2 (0.91, 1.7)
|
1.1(0.83, 1.5)
|
|
Temporality^ of SSRI prescription
| | | | |
|
Never
|
338/12872
|
2.6
|
1.0
|
1.0
|
|
Current
|
14/201
|
7.0
|
2.7 (1.6, 4.4)
|
2.3 (1.4, 3.9)
|
|
Former
|
37/1391
|
2.7
|
1.0 (0.72, 1.4)
|
0.93 (0.66, 1.3)
|
- Risk of re-operation occurring in the first fourteen days after surgery was estimated in never, ever, current and former users.
- Current users were defined as women with a prescription of SSRI within 30 days before initial breast cancer surgery.
- Former users were defined as women with a prescription of SSRI more than 30 days before initial breast cancer surgery.
-
# Women diagnosed in Northern Denmark between 1996 and 2007 with complete prescription coverage since 1999.
- ^Temporality of current use of SSRI was defined as prescriptions within 30 days prior to admission for surgery.
- *Adjusted for age
- SSRI = Selective serotonin reuptake inhibitors, RR = risk ratio, CI = 95% confidence interval
